Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12,733,410
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
4,725,811
-
Shares change
-
-49,587
-
Total reported value, excl. options
-
$158,784,781
-
Value change
-
-$1,638,874
-
Number of buys
-
37
-
Number of sells
-
-25
-
Price
-
$33.59
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q3 2021
74 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q3 2021.
IRADIMED CORP - Common Stock (IRMD) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,725,811 shares
of 12,733,410 outstanding shares and own 37.11% of the company stock.
Largest 10 shareholders include Nine Ten Capital Management LLC (761,619 shares), RENAISSANCE TECHNOLOGIES LLC (702,712 shares), Soleus Capital Management, L.P. (450,679 shares), BlackRock Inc. (416,845 shares), VANGUARD GROUP INC (405,437 shares), Ranger Investment Management, L.P. (217,829 shares), Russell Investments Group, Ltd. (185,689 shares), RK Capital Management, LLC (147,319 shares), Mondrian Investment Partners LTD (136,998 shares), and RICE HALL JAMES & ASSOCIATES, LLC (120,399 shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.